Low dosage combined adrenaline-guanethidine formulations in the management of chronic simple glaucoma.
D000328:Adult; D000368:Aged; D000818:Animals; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003228:Conjunctiva; D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006145:Guanethidine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D011817:Rabbits; D013997:Time Factors
D009883:Ophthalmic Solutions; D004837:Epinephrine; D006145:Guanethidine